Literature DB >> 22320993

Expressional alterations and transcript isoforms of metastasis suppressor genes (KAI1 and KiSS1) in breast cancer patients.

S Mooez1, F A Malik, M A Kayani, R Rashid, A Zahid, A Khan.   

Abstract

BACKGROUND: Metastasis suppressor genes are involved in the inhibition of a cancer cell's ability to metastasize. Down expression of such genes may contribute to pathogenesis of breast cancer. The aim of current study was firstly to evaluate expression of two examples, KAI1 and KISS1, and then to determine relationships with stages of breast cancer in a Pakistani population.
METHODOLOGY: Fresh biopsy tissues were collected from different hospitals and oncology research institutes. The semi quantitative reverse transcriptase polymerase chain reaction was used to investigate KAI1 and KISS1 expression in 25 breast tumor tissues and 25 normal tissues. Statistical analysis was performed to explore its association with breast cancer risk.
RESULTS: The present study revealed that KAI1 and KISS1 mRNA expression was markedly reduced in tissues of breast cancer compared to adjacent normal tissue. In present study a splice variant of KAI1 during a screen for its expression analysis was also observed. This splice variant has not been reported previously.
CONCLUSIONS: Metastasis suppressor genes demonstrate reduced expression in breast cancers in Pakistan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22320993

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

1.  KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.

Authors:  Shao-Qin Chen; Zhi-Hua Chen; Su-Yong Lin; Qi-Bao Dai; Leng-Xi Fu; Rui-Qing Chen
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro.

Authors:  Hui Yan; Xunda Ji; Jing Li; Lei Zhang; Peiquan Zhao
Journal:  Oncol Lett       Date:  2016-12-16       Impact factor: 2.967

Review 3.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Nm23-H1 was involved in regulation of KAI1 expression in high-metastatic lung cancer cells L9981.

Authors:  Jiacong You; Rui Chang; Bin Liu; Lingling Zu; Qinghua Zhou
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

5.  Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma.

Authors:  Jing Xu; Yu Zhang; Yichao Wang; Xiaoying Tao; Lili Cheng; Shiwu Wu; Yisheng Tao
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

6.  Polymorphisms rs12998 and rs5780218 in KiSS1 suppressor metastasis gene in Mexican patients with breast cancer.

Authors:  Edhit Guadalupe Cruz Quevedo; Gabriela Monserrat Mimendi Aguilar; Luis Anselmo Juárez Aguilar; Susan Andrea Gutierrez Rubio; Silvia Esperanza Flores Martínez; Ingrid Patricia Dávalos Rodríguez; José Sánchez Corona; Martha Isabel Torres Morán; Roberto Carlos Rosales Gómez; María Cristina Morán Moguel
Journal:  Dis Markers       Date:  2015-02-24       Impact factor: 3.434

7.  KiSS1 inhibits growth and invasion of osteosarcoma cells through inhibition of the MAPK pathway.

Authors:  Y Zhang; Y J Tang; Z H Li; F Pan; K Huang; G H Xu
Journal:  Eur J Histochem       Date:  2013-10-29       Impact factor: 3.188

Review 8.  Kisspeptin/KISS1R System in Breast Cancer.

Authors:  Donna Cvetković; Andy V Babwah; Moshmi Bhattacharya
Journal:  J Cancer       Date:  2013-09-26       Impact factor: 4.207

9.  Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.

Authors:  Lan Yu; Lei Zhou; Shiwu Wu; Xiaomeng Gong; Zhenzhong Feng; Li Ma; Bo Zhu; Nan Yao; Danna Wang; Huiming Dong
Journal:  World J Surg Oncol       Date:  2014-04-24       Impact factor: 2.754

10.  Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.

Authors:  Zahra Rasoulzadeh; Roya Ghods; Tohid Kazemi; Ebrahim Mirzadegan; Nassim Ghaffari-Tabrizi-Wizsy; Simin Rezania; Somaieh Kazemnejad; Soheila Arefi; Jamileh Ghasemi; Sedigheh Vafaei; Ahmad-Reza Mahmoudi; Amir-Hassan Zarnani
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.